Contractile responsiveness of ventricular myocytes to isoproterenol is regulated by induction of nitric oxide synthase activity in cardiac microvascular endothelial cells in heterotypic primary culture

Circulation Research

Volumn 77, Issue 3, 1995, Pages 486-493

  Ungureanu Longrois, Dan ^e   Balligand, Jean Luc ^e   Okada, Ikutaro ^e   Simmons, William W ^e   Kobzik, Lester ^a,b   Lowenstein, Charles J ^c   Kunkel, Steven L ^d   Michel, Thomas ^e   Kelly, Ralph A ^a   Smith, Thomas W ^e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e NONE

Author keywords

Interferon ; Interlcukin 1; Interleukin 1 receptor antagonist; Transforming growth factor

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; ISOPRENALINE; MESSENGER RNA; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; POLYCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INDUCTION; HEART MUSCLE CELL; HEART VENTRICLE; LUNG ALVEOLUS MACROPHAGE; MICROVASCULATURE; MUSCLE FIBER CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT;

AMINO ACID OXIDOREDUCTASES; ANIMAL; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HEART VENTRICLE; INTERLEUKIN-1; ISOPROTERENOL; LIPOPOLYSACCHARIDES; MALE; MYOCARDIAL CONTRACTION; NITRIC OXIDE; NITRIC-OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029150631     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.77.3.486     Document Type: Article

References (40)

1. Krämer BK, Nishida M, Kelly RA, Smith TW. Endothelins: myocardial actions of a new class of cytokines. Circulation. 1992;85: 350-356.
2. Brutsacrt DL, Andries LJ. The endocardial endothelium. Am J Physiol. 1992;263:H985-H1002.
3. Kumar S, West DC, Ager A. Heterogeneity in endothelial cells from large vessels and mierovessels. Differentiation. 1987;36:57-70.
4. Gerritsen ME, Niedhala MJ, Szczepanski A, Carley WW. Cytokine activation of human macro- and microvessel-derived endothelial cells. In: Blood Cells. New York, NY: Springer-Verlag; 1993: 325-339.
5. Lelkes PI. Conference report: endothelial cell heterogeneity and organ specificity. Endothelium. 1993;1:69-70.
6. Gerritsen ME, Bloor CM. Endothelial cell gene expression in response to injury. FASEB. J. 1993;7:523-532.
7. Nishida M, Springhorn JP, Kelly RA, Smith TW. Cell-cell signalling between adult rat ventricular myocytes and cardiac microvascular endothelial cells in heterotypic primary culture. J Clin Invest. 1993; 91:1934-1941.
8. Balligand J-L. Ungureanu D, Kelly RA, Kobzik L, Pimentai D, Michel T, Smith TW. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest. 1993:91:2314-2319.
9. Balligand J-L, Ungureanu-Longrois D, Simmons WW, Kobzik L, Lowenstein CJ, Lamas S, Kelly RA, Smith TW, Michel T. Induction of NO synthase in cardiac microvascular endothelial cells: IL-1β and IFNγ promote transcription of an endothelial iNOS. Am J Physiol. 1995;268:H1293-H1303.
10. Balligand J-L, Kelly RA, Marsden PA, Smith TW, Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signalling system. Proc Natl Acad Sci USA. 1993;90:347-351.
11. Nishida M, Carley WW, Gerritsen ME, Ellingsen Ø, Kelly RA, Smith TW. Isolation and characterization of human and rat cardiac microvascular endothelial cells. Am J Physiol. 1993;264:H639-H652.
12. Claycomb WC, Palazzo MC. Culture of the terminally differentiated adult cardiac muscle cell: a light and scanning electron microscopic study. Dev Biol. 1980;80:466-482.
13. Berger H-J, Prasad SK, Davidoff AJ, Pimental D, Ellingsen Ø, Marsh JD, Smith TW, Kelly RA. Continual electric field stimulation preserves contractile function of adult ventricular myocytes in primary culture. Am J Physiol. 1994;266:H344-H349.
14. Volz A, Piper HM, Siegmund B, Schwartz P. Longevity of adult ventricular rat heart muscle cells in serum-free primary culture. J Mol Cell Cardiol. 1991;23:161-173.
15. Ellingsen Ø, Davidoff AJ, Prasad SK, Berger H-J, Springhorn JP, Marsh JD, Kelly RA, Smith TW. Adult rat ventricular myocytes cultured in defined medium: phenotype and electromechanical function. Am J Physiol. 1993;265:H747-H754.
16. Gross SS, Levi R. Tetrahydrobiopterin synthesis: an absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J Biol Chem. 1992;267:25722-25729.
17. Lowenstein CJ, Glatt C, Brett D, Snyder S. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci USA. 1991;89:6711-6715.
18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
19. MacLellan WR, Brand T, Schneider MD. Transforming growth factor-β in cardiac ontogeny and adaptation. Circ Res. 1993;73: 783-791.
20. Sporn MB, Roberts AB. Transforming growth factor-β: recent progress and new challenges. J Cell Biol. 1992;119:1017-1021.
21. Balligand J-L, Ungureanu-Longrois D, Pimental D, Malinski TA, Kapturczak M, Taha Z, Lowenstein CJ, Davidoff AJ, Kelly RA, Smith TW, Michel T. Cytokine-inducible nitric oxide synthase (iNOS) expression in adult rat ventricular myocytes: characterization and regulation of iNOS isoform expression and detection of iNOS activity in single cardiac myocytes in vitro. J Biol Chem. 1994; 269:27580-27588.
22. Vodovotz Y, Bogdan C, Paik J, Xie Q-W, Nathan CF. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β. J Exp Med. 1993;178:605-613.
23. Roberts AB. Vodovotz Y, Roche NS. Sporn MB, Nathan CF. Role of nitric oxide in antagonistic effects of transforming growth factor-β and interleukin-1β on the beating rate of cultured cardiac myocytes. Mol Endocrinol. 1992;6:1921.
24. Junquero DC, Scott-Burden T, Schini VB. Vanhoutte PM. Inhibition of cytokinc-induced nitric oxide production by transforming growth factor-β1 in human smooth muscle cells.J Physiol (Lond). 1992;454:451.
25. 2 inhibits interleukin 1β- and tumor necrosis factor α-induction of nitric oxide synthase in rat renal mesangial cells. Biochem Biophys Res Commun. 1991;175:372.
26. Borzak SS, Murphy S, Marsh JD. Mechanisms of rate staircase in rat ventricular cells. Am J Physiol. 1991;260:H884-H892.
27. Ungureanu-Longrois D, Balligand J-L, Okada I, Simmons WW, Kobzik L, Lowenstein CJ, Kunkel SL, Michel T, Kelly RA, Smith TW. Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to β-adrenergic agonists. Circ Res. 1995: 77:494-502.
28. Li K, Rouleau JL, Andries LJ, Brutsaert DL. Effect of dysfunctional vascular endothelium on myocardial performance in isolated papillary muscles. Circ Res. 1993;72:768-777.
29. Ramaciotti C, Sharkey A, McClellan G, Winegrad S. Endothelial cells regulate cardiac contractility. Proc Natl Acad Sci USA. 1992; 89:4033-4036.
30. Ramaciotti C, McClellan G, Sharkey A, Rose D, Weisberg A, Winegrad S. Cardiac endothelial cells modulate contractility of rat heart in response to oxygen tension and coronary flow. Circ Res. 1993;72:1044-1064.
31. McClellan G, Weisberg A, Lin L-E, Rose D, Ramaciotti C, Winegrad S. Endothelial cells arc required for the cAMP regulation of cardiac contractile proteins. Proc Natl Acad Sci USA. 1993;90: 2885-2889.
32. Kent RL, Mann DL, Urabe Y, Hisano R, Hewett KW, Loughnane M, Cooper G IV. Contractile function of isolated feline cardiocytes in response to viscous loading. Am J Physiol. 1989;257:H1717-H1727.
33. Brady AJB, Poole-Wilson PA, Harding SE, Warren JB. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol. 1992;263:H1963-H1966.
34. Malinski T, Taha Z. Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature. 1992;358: 676-678.
35. Malinski T, Taha Z, Grunfeld S, Patton S, Kapturczak M, Tomboulian P. Diffusion of nitric oxide in the aorta wall monitored in situ by porphyrinic microsensors. Biochem Biophys Res Commun. 1993;193:1076-1082.
36. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 1992;258:1898-1902.
37. Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell. 1994;78:931-936.
38. Knowles RG, Moncada S. Nitric oxide as a signal in blood vessels. Trends Biochem Sci. 1992;17:399-402.
39. Rakusan K, Flanagan MF, Geva T, Southern J, Van Praagh R. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation. 1992;86:38-46.
40. Ungureanu-Longrois D, Balligand J-L, Kelly RA, Smith TW. Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. J Mol Cell Cardiol. 1995;27:155-167.